Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 9, Pages e72843
Publisher
Public Library of Science (PLoS)
Online
2013-09-05
DOI
10.1371/journal.pone.0072843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
- (2013) Russell C. Langan et al. Journal of Cancer
- A systematic comparison of genome-scale clustering algorithms
- (2012) Jeremy J Jay et al. BMC BIOINFORMATICS
- Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis
- (2012) Shih-Pei Lin et al. CANCER LETTERS
- Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis
- (2012) Matthew R. Dallas et al. FASEB JOURNAL
- A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy
- (2012) Qin Mao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients
- (2012) Claudio Coco et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells
- (2011) Phil-Sun Oh et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence
- (2011) A. Gerger et al. CLINICAL CANCER RESEARCH
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Postoperative Adjuvant Chemotherapy for Stage II Colorectal Cancer: A Systematic Review of 12 Randomized Controlled Trials
- (2011) Xiaojian Wu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis
- (2011) Xiaodong Huang et al. SURGICAL ONCOLOGY-OXFORD
- Isolation and Propagation of a Human CD133- Colon Tumor-Derived Cell Line with Tumorigenic and Angiogenic Properties
- (2010) Nalú Navarro-Alvarez et al. CELL TRANSPLANTATION
- CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential
- (2010) Guangqiu Li et al. CLINICAL & EXPERIMENTAL METASTASIS
- Colon cancer stem cells: implications in carcinogenesis
- (2010) Matthew et al. Frontiers in Bioscience-Landmark
- Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
- (2009) R. Artells et al. EUROPEAN JOURNAL OF CANCER
- The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
- (2009) David Horst et al. JOURNAL OF PATHOLOGY
- Biomolecular Characterization of CD44-Fibrin(ogen) Binding
- (2008) Christina S. Alves et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now